Newer Phosphodiesterase Inhibitors: Comparison with Established Agents
Urologic Clinics of North America, 08/19/2011
McNamara ER et al. – Erectile dysfunction is defined as the consistent or recurrent inability to attain or maintain penile erection sufficient for sexual performance. Self–reported erectile dysfunction has increased significantly as men seek effective therapy, such as oral phosphodiesterase 5 inhibitors (PDE5i). PDE5i are now the drugs of choice in the initial therapy of erectile dysfunction. This review compares the currently available PDE5i with the second–generation PDE5i, which are soon to be available.